Vaccine approaches to treat urothelial cancer

GC Giudice, GP Sonpavde - Human Vaccines & …, 2024 - Taylor & Francis
Bladder cancer (BC) accounts for about 4% of all malignancies. Non-muscle-invasive BC,
75% of cases, is treated with transurethral resection and adjuvant intravesical instillation …
被引用次数：1 相关文章
[HTML] nih.gov

[HTML][HTML] Vaccine approaches to treat urothelial cancer

GC Giudice, GP Sonpavde - Human Vaccines & …, 2024 - pmc.ncbi.nlm.nih.gov
Bladder cancer (BC) accounts for about 4% of all malignancies. Non-muscle-invasive BC,
75% of cases, is treated with transurethral resection and adjuvant intravesical instillation …

Vaccine approaches to treat urothelial cancer

GC Giudice, GP Sonpavde - Human vaccines & …, 2024 - pubmed.ncbi.nlm.nih.gov
Bladder cancer (BC) accounts for about 4% of all malignancies. Non-muscle-invasive BC,
75% of cases, is treated with transurethral resection and adjuvant intravesical instillation …

Vaccine approaches to treat urothelial cancer.

GC Giudice, GP Sonpavde - Human Vaccines & …, 2024 - europepmc.org
Bladder cancer (BC) accounts for about 4% of all malignancies. Non-muscle-invasive BC,
75% of cases, is treated with transurethral resection and adjuvant intravesical instillation …

Vaccine approaches to treat urothelial cancer

GC Giudice, GP Sonpavde - Human Vaccines & …, 2024 - Taylor & Francis
Bladder cancer (BC) accounts for about 4% of all malignancies. Non-muscle-invasive BC,
75% of cases, is treated with transurethral resection and adjuvant intravesical instillation …